BackgroundStudies have highlighted the effects the use of the WHO Surgical Safety Checklist can have on lowering mortality and surgical complications. Implementation of the checklist is not easy and several barriers have been identified. Few studies have addressed personnel’s acceptance and attitudes toward the WHO Surgical Safety Checklist. Determining personnel’s acceptance might reflect their intention to use the checklist while their awareness and knowledge of the checklist might assess the effectiveness of the training process.MethodsThrough an anonymous self- responded questionnaire, general characteristics of the respondents (age, gender, profession and years spent studying or working at the hospital), knowledge of the WHO Surgical Safety Checklist (awareness of existence, knowledge of objectives, knowledge of correct use), acceptance of the checklist and its implementation (including personal belief of benefits of using the checklist), current use, teamwork and safety climate appreciation were determined.ResultsOf the 147 surgical personnel who answered the questionnaire, 93.8% were aware of the existence of the WHO Surgical Safety Checklist and 88.8% of them reported knowing its objectives. More nurses than other personnel knew the checklist had to be used before the induction of anesthesia, skin incision, and before the patient leaves the operating room. Most personnel thought using the WHO Surgical Safety Checklist is beneficial and that its implementation was a good decision. Between 73.7% and 100% of nurses in public and private hospitals, respectively, reported the checklist had been used either always or almost always in the general elective surgeries they had participated in during the current year.ConclusionsDespite high acceptance of the checklist among personnel, gaps in knowledge about when the checklist should be used still exist. This can jeopardize effective implementation and correct use of the checklist in hospitals in Guatemala City. Efforts should aim to universal awareness and complete knowledge on why and how the checklist should be used.

No abstract

HighlightsSagliker syndrome is assumed to result from insufficient treatment of secondary hyperparathyroidism in early stages of chronic renal failure.Sagliker syndrome should be added to current surgical indications for parathyroidectomy.

Key Clinical MessageSporadic Medullary Carcinoma of the Thyroid is a relatively uncommon entity and at the time of diagnosis, most already present loco‐regional metastasis. Therapy should be aggressive to reduce recurrence and mortality. Follow‐up period should continue lifelong and should also include calcium/pentagastrin infusion test, as well as 6‐month interval diagnostic imaging.

Introducción: El uso de cámaras de luz con longitudes de onda en el espectro del infrarrojo cercano (IRC) y la angiografía con verde de indocianina (VI), permiten visualizar y determinar la perfusión de las glándulas paratiroides. Objetivos: Determinar diferencia en la viabilidad de las glándulas paratiroides después de la aplicación de VI a una dosis de 0.01mg/kg contra una dosis de 0.02mg/kg de peso. Metodología: Se obtuvo una muestra de 20 pacientes operados por patología tiroidea, divididos aleatoriamente en dos grupos. Durante la cirugía se registró el número de glándulas paratiroides identificadas visualmente bajo luz de xenón convencional y por autofluorescencia en el espectro IRC. Posteriormente, se inyecto por vía endovenosa VI a una dosis de 0.01mg/kg en el grupo A y a una dosis de 0.02mg/kg en el grupo B. Después de la inyección del colorante, se midió con una escala colorimétrica la perfusión de las glándulas paratiroides. Resultados: Se identificaron un total de 37 glándulas paratiroides bajo luz de xenón convencional y 42 glándulas paratiroides por autofluorescencia en el espectro IRC (p=0.4152). La diferencia entre la determinación de la viabilidad de las glándulas paratiroides con luz de xenón convencional y por angiografía después de la inyección de VI no fue significativa (p=0.5714). Tampoco hubo diferencia entre el grupo A y B (p=1). Conclusiones: No hubo diferencia en la determinación de la perfusión de las glándulas paratiroides utilizando una dosis de VI de 0.01mg/kg o una dosis de 0.02mg/kg.